Additional results from the TRIUMPH program, which include a maintenance dose of 4 mg in addition to the 9 mg and 12 mg doses tested in this trial, are expected in 2026
These often improve over time as your body adjusts
Best for: People who cannot use any GLP-1 class medication, or as an add-on to boost results
All results and testimonials are representative of individual altRx member experiences only.
In c-MET-overexpressing SCLC cell line NCI-H69, hepatocyte growth factor (HGF) dramatically induced c-MET phosphorylation at phosphoepitopes pY1230/1234/1235 (catalytic tyrosine kinase), pY1003 (juxtamembrane), and also of paxillin at pY31 (CRKL-binding site)
You can also read the peptide buying guide, review research supply information, or visit the payment FAQ before placing an order